Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes.
The International journal of biological markers·2007
Impairment of the antiproliferative effect of glucocorticosteroids by 11beta-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cells.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2004
11beta-hydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturation.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2002
[Neuroendocrine tumors of the stomach (stomach carcinoid)].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Mental suffering IN patients with parkinsonism].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Liver transplantation 1994].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Diagnosis and therapy of portosystemic encephalopathy].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Ascites].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.
JTO clinical and research reports·2026
Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
B-cells in breast cancer: current insights and challenges.
Frontiers in oncology·2026
The heterogeneous and dynamic immune-tumor interface in breast cancer.
Frontiers in oncology·2026